CompletedNot Applicable

Treatment of Rheumatoid Hand With Magnetotherapy

Poland72 participantsStarted 2021-03-01

Plain-language summary

Brief Summary: Participants with rheumatoid arthritis with recommendation to physiotherapy. Created 2 study groups: 1. Kinesiotherapy with static magnetic field 2. Kinesiotherapy with low-frequency pulsed magnetic field Pulsed magnetic field give better effects then static magnetic field.

Who can participate

Age range

35 Years – 80 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Informed voluntary consent to participate in the study
. II ° and III ° of advancement of radiological changes
. II ° and III ° of advancement of functional changes
. Remission, low or moderate RA activity: DAS28
. Medical referral for physiotherapy treatment

Exclusion criteria

. Additional physiotherapy treatments for the hands
. Contraindications for magnetotherapy treatments
. Lack of informed, voluntary consent to participate in the study

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Visual Analogue Scale

Timeframe: Change from baseline VAS value immediately after therapy.

Health Assesment Questionaire

Timeframe: Change from baseline HAQ-20 value immediately after therapy.

Range of motion

Timeframe: Change from baseline range of motion value immediately after therapy.

Displacement hand volume measurement

Timeframe: Change from baseline volume value immediately after therapy.

Persistence time of morning stiffness

Timeframe: Change from baseline time of morning stiffness value immediately after therapy.

Severity of morning stiffness

Timeframe: Change from baseline time of severity of morning stiffness value immediately after therapy.

Trial details

NCT IDNCT05920746

SponsorJolanta Zwolińska

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-11-01

View on ClinicalTrials.gov More Rheumatoid Arthritis trials